Clinical Trials Arena on MSN12d
Immunovant will not seek approval for MG therapy, despite hitting endpoints
The company plans to use results from its Phase III myasthenia gravis study to support its pipeline candidate IMVT-1402 over ...
Hosted on MSN12d
Immunovant, Roivant slip after trial data for autoimmune disorder therapy
Meanwhile, initial data from 73 patients who took part in its Phase 2b CIDP study suggested a 1.8-point improvement in a ...
Baylor College of Medicine4y
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...
Medscape9d
Diabetic Neuropathy--A Review
Conversely, the focal diabetic neuropathies, which are often associated with inflammatory vasculopathy on nerve biopsies, remain self-limited, sometimes after a relapsing course. Diabetes mellitus ...
Bellevue Reporter5d
Arialief Neuropathy Support – Daily Supplement for Healthy Nerves & Reduced Inflammation
Neuropathy presents an array of challenges ... By utilizing a unique formula of ingredients chosen for their anti-inflammatory and neuroprotective properties, Arialief aims to provide users ...
Sacramento Bee19d
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric ...